Terminal Metabolites of Niacin Promote Vascular Inflammation and Contribute to Cardiovascular Disease Risk
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Nature Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Nat. Med. 2024 Feb 01;30(2)424-434, M Ferrell, Z Wang, JT Anderson, XS Li, M Witkowski, JA DiDonato, JR Hilser, JA Hartiala, A Haghikia, T Cajka, O Fiehn, N Sangwan, I Demuth, M König, E Steinhagen-Thiessen, U Landmesser, WHW Tang, H Allayee, SL HazenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.